Orange Book product · Brand (NDA)
BUTAZOLIDIN
PHENYLBUTAZONE
At a glance
Approved Prior to Jan 1, 1982
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
No patent or exclusivity dates are listed for this product.
Pharmaceutical detail
Active ingredient
PHENYLBUTAZONE
Strength
100MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 008319
Product number
009
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 1985PHENYLBUTAZONEGeneric (ANDA)
ANDA 088994 · SUN PHARM INDUSTRIES
- 1985PHENYLBUTAZONEGeneric (ANDA)
ANDA 088863 · SUN PHARM INDUSTRIES
- 1983PHENYLBUTAZONEGeneric (ANDA)
ANDA 088218 · IVAX PHARMS
- 1982PHENYLBUTAZONEGeneric (ANDA)
ANDA 087756 · WATSON LABS
- 1982PHENYLBUTAZONEGeneric (ANDA)
ANDA 087774 · CHARTWELL RX
- 1982PHENYLBUTAZONEGeneric (ANDA)
ANDA 087674 · WATSON LABS
- —AZOLIDGeneric (ANDA)
ANDA 087260 · SANOFI AVENTIS US
- —AZOLIDGeneric (ANDA)
ANDA 087091 · SANOFI AVENTIS US
- —PHENYLBUTAZONEGeneric (ANDA)
ANDA 084339 · FOSUN PHARMA
- —PHENYLBUTAZONEGeneric (ANDA)
ANDA 086151 · WATSON LABS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
